Antimicrobial resistance

Antimicrobial resistance

Antimicrobial resistance is a global crisis that threatens public health and modern medicine.

This page showcases some of the research undertaken by the European Observatory on Health Systems and Policies on this growing challenge and the evidence that has been generated on the effects of the crisis on European health systems.



Publications

One Health in Europe: from concept to practice

The One Health approach is essential to address modern global health challenges. It integrates human, animal, plant, and environmental health to prevent, predict, and combat threats like pandemics, zoonoses, and antimicrobial resistance (AMR). With AMR estimated to claim millions of lives annually by 2050, the European Commission has implemented cross-policy strategies, including stringent EU veterinary regulations and targeted funding for national AMR action plans. Climate change further exacerbates health risks, highlighting the need for robust One Health frameworks. Collaborative efforts, including global partnerships and events like the European Public Health Conference, underscore the Commission’s commitment to sustainable, interconnected health solutions.

The socioeconomic drivers and impacts of Antimicrobial Resistance (AMR): Implications for policy and research

Read interactivelyKey messagesThe policy community, international and national, recognizes the significant health and economic impacts of antimicrobial...

Strengthening the EU response to prevention and control of Antimicrobial Resistance (AMR): Policy priorities for effective implementation

Read interactivelyThis brief’s key messages are: Antimicrobial resistance (AMR) is a major global public health challenge. It is driven by inappropriate...

One Health in action: Antimicrobial resistance in the animal health sector

Recent global and European Union (EU) policy actions on antimicrobial resistance (AMR) are important to tackle the huge risks posed by antibiotic-resistant...

How can the EU support sustainable innovation and access to effective antibiotics?: Policy options for existing and new medicines

The key messages of this policy brief published by the European Observatory on Health Systems and Policies are as follows:Antimicrobial and particularly...

Risk communication for cross-border health threats

The threat posed by anti-microbial resistant pathogens, especially in the context of health care associated infections, has taken on an increasingly pan-European...

The Netherlands EU Presidency on health

With several other pressing policy areas dominating the agenda of the Netherlands Presidency of the European Union, health issues still feature as valuable...

Health priorities of Slovak EU Presidency

The Slovak Republic, which will be is at the helm of the Council of the European Union until the end of the year, has embraced some key health priorities,...

Fostering clinical development

Novel antibiotics are desperately needed to combat progressively resistant strains of bacteria, but there are too few innovative antibiotics in the clinical...

Tackling AMR in the community

Antimicrobial resistance is an important societal issue. Making sure patients in the community get the right antibiotic at the right time is important...

Quantifying the benefits of vaccines

Vaccination is one of the most effective measures to reduce antimicrobial resistance. As vaccines are highly specific to their targeted pathogens, they...

Strengthening implementation of AMR

Antimicrobial resistance is one of the major challenges of our time. Countries use national action plans as a mechanism to build engagement among stakeholders...

Tackling antimicrobial resistance

Health is a global issue and tackling many of the greatest health threats of our time requires concerted multilateral and cross-sectoral collaboration...

Averting the AMR crisis: what are the avenues for policy action for countries in Europe?

This Observatory policy brief summarizes some of the key policy avenues for tackling antimicrobial resistance (‎AMR)‎. Following the widely accepted...

The role of public health organizations in addressing public health problems in Europe: the case of obesity, alcohol and antimicrobial resistance

Growing levels of obesity (‎‎including among children)‎‎, continued harmful consumption of alcohol and the growing threat of antimicrobial...

The role of public health organizations in addressing public health problems in Europe: the case of obesity, alcohol and antimicrobial resistance

This online publication has been issued by the European Observatory on Health Systems and Policies and is envisaged as an appendix to the analytical volume...

Organization and financing of public health services in Europe

How are public health services in Europe organized and financed? With European health systems facing a plethora of challenges that can be addressed through...

Targeting innovation in antibiotic drug discovery and development: the need for a One Health–One Europe–One World Framework

Antimicrobial resistance is a global crisis that threatens public health and modern medicine. The discovery and development of novel antibiotic products...

Policies and incentives for promoting innovation in antibiotic research

High levels of pathogen resistance are rendering current antibiotics obsolete. Coupled with insufficient investment in discovering new treatments, multidrug-resistant...

Subscribe to our newsletter

Sign Up